EURETINA 2021: Patients With nAMD Show a High Rate of Nonadherence to anti-VEGF therapy
The impact of the pandemic on nonadherence will be considered in additional analyses.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.